See other companies on Welcome to the Jungle
Concr
Enabling precision diagnostics
- 1-20 employees
- B2B
- Deep Tech
- Machine Learning
- MedTech
- Esher, UK
Jump to section
Company mission
To enable biopharma, diagnostics, and healthcare industries to discover better ways to overcome cancer.
Our take
Over 90% of novel cancer drugs fail early in clinical trials. While this leads to the generation of more data, its value is limited unless it can be interlinked to generate biological insights. Concr is a techbio company that is pioneering a new approach to precision oncology. Its statistical learning-powered biomarker prediction engine uses established methods from astrophysics to accurately predict patient-specific biomarkers of response to novel and existing cancer therapies.
Its online platform, FarrSight, enables users to store, manage, and analyse all data from one place, easily generating meaningful actionable insights for cost-effective drug development and patient treatment. Its proprietary data modelling integrates disparate data and tests from across the pipeline and different indications, overall making actionable predictions using 300x less pre-clinical and 7x less clinical data.
The company closed a seed funding round in March 2023, which is being used to enhance its scientific and product development and grow its portfolio of pharmaceutical partnerships. Concr is well placed to see continued growth, as its biomarker prediction engine is set to deliver lifesaving insights to patients around the globe.
Freddie
Company Specialist at Welcome to the Jungle
Funding (last 2 of 4 rounds)
May 2023
$1.6m
SEED
May 2022
$1.6m
SEED
Total funding: $3.7m
This company has top investors
Leadership
Matthew Foster
(CEO)Former Graduate Student in Biomedical Engineering, Associate Researcher at Imperial College London, and Biological Engineering Founder at Deep Science Ventures.
Matthew Griffiths
(CTO)Former PhD student at the University of Cambridge and Founder of Deep Science Ventures.
Uzma Asghar
(CSO)Current Medical Oncologist Consultant at The Royal Marsden NHS Foundation Trust and North Middlesex University Hospital NHS Trust. Former Senior Clinical Research Fellow at University College London Hospitals.